|
Post by ilovekauai on May 13, 2019 16:41:10 GMT -5
Is our IR person Rose A salary really $500K per year and does she get a raise too tomorrow? Her response to shareholder concerns about the ASM being in NYC was defensive and condescending IMO. Managment wanted east coast this year then fine, but Danbury should've been the venue. Sorry, but I don'r buy the excuse that other biz was happening in NY to justify the expense of The Warwick Hotel. I'd love to see the bill from that hotel for the staff staying there at $700 per night + +! Hey, room service anyone? I'll take one of those ala carte $60 breakfasts please, and toss in a bottle of top shelf champagne with fresh squeezed OJ for my mimosas.
|
|
|
Post by ilovekauai on May 12, 2019 17:59:36 GMT -5
If Afrezza goes away rest assured that the rich are already stockpiling it and will have enough to last for years afterwards, till a new powdered insulin hits the market and is marketed in the correct way that has solid global connections. It won't be a "niche product" next time around. I got that same "niche" line two years in a row now from my current endo just last month. And we wonder why MNKD is stagnant in sales?
But, I'm sure management will dazzle investors with "veins of gold" stories in NYC this week at the ASM in the $650 per room, per night, hotel. I'll say it one more time; the ASM should've been held again at MNKD corporate headquarters in Thousand Oaks, to allow more investors to attend. IMO, management bailed on us. And I'll say this one more time; I hope Sanofi burns in hell for what they pulled on MNKD. That was a total set-up from the get go and MNKD fell for it. Al Mann was ill by then and I suspect his usual rock solid judgement was already impaired. Al was desperate to nail down a global partner for Afrezza and rightly so. That move was a taken risk out of necessity that quickly collapsed. Sanofi played MNKD like a Stradivari violin. Thank you.
|
|
|
Post by ilovekauai on May 11, 2019 14:58:34 GMT -5
Yes, but the r/s really rattled me and stole over 100K shares from me. That was so brutal and still struggle in my head over that manuver.
|
|
|
Post by ilovekauai on May 7, 2019 8:40:20 GMT -5
$650 a night plus tax to stay at The Warick Hotel in NY where the ASM is next week. Just saying.
|
|
|
Post by ilovekauai on May 7, 2019 8:03:55 GMT -5
Where is the shoutbox?
|
|
|
Post by ilovekauai on May 4, 2019 20:05:39 GMT -5
I watched the interview of Kendall in its entirety today. It was good and and the person conducting the interview was good too. Mayne I'm being too harsh on Kendall lately. Guess I'll step back from that and just shout my big trap and give this all more time. Thank you!
|
|
|
Post by ilovekauai on May 4, 2019 14:48:04 GMT -5
I just went to the insuling savings website and looked up endos who're willing to prescribe Afrezza in my area. Interestingly enough, my endo was included in the list yet when I saw her last week, she showed zero interest in prescribing me Afrezza and actually talked it down as I've mentioned before here in other posts. How can this possibly be? How can she be listed as a provider, be so restitant to prescribing, and actually talk doen the product? This makes no sense whasoever. I'm very confused about this. Why is she lsited there in the first place?
|
|
|
Post by ilovekauai on Apr 16, 2019 13:18:23 GMT -5
Mnh: I've been asking for years, long before Kendall, for exposure in major medical journals. And, yes please ask what Kendall is doing. It's been a year now since he came on board.
Stock W: I was one of those enthusiastic shareholders at the ASM. I thought Kendall coming on board was the greatest thing since sliced bread for MNKD. I truly expected big things, and fast, from the "veins of gold" Kendall pointed out that he found in Afrezza. It's now a year later. Well?
|
|
|
Post by ilovekauai on Apr 15, 2019 23:51:38 GMT -5
Just an FYI; at last year's ASM we got like 4 questions in, (if that), and answers were-long winded that quickly veered off-topic. Just saying. It seemed to me at least, that the ASM was a really poor venue to try and get responses. But what do I know; this year could be different; it is after all being held in mid-town Manhattan, my absolute first choice for an ASM where the host company has no anchor. Cheers.
|
|
|
Post by ilovekauai on Apr 4, 2019 12:54:10 GMT -5
Boca1: Danbury is also a legitimate venue for holding the ASM, and alternating between there and Thousand Oaks makes sense. Thank you for pointing that out.
|
|
|
Post by ilovekauai on Apr 3, 2019 18:14:04 GMT -5
Until this all gets sorted out, no bonuses, no raises, no more Hawaii for upper management staff. Nada. And, I'm still steamed about the ASM being moved to NYC this year, at a swanky hotel, instead of at corporate headquarters in Thousand Oaks, CA where it should always be held w/o any hesitation or venue move. I feel disenfranchised and will not be traveling to NYC. Nice move to avoid distraught shareholders asking pointed questions? You be the judge. Thank you.
|
|
|
Post by ilovekauai on Apr 1, 2019 6:40:22 GMT -5
Nice news, except it's a $12.5 payment, not $125M payment. The link won't let me fix it!
|
|
|
Post by ilovekauai on Apr 1, 2019 6:40:00 GMT -5
|
|
|
Post by ilovekauai on Mar 31, 2019 19:30:02 GMT -5
Never fear my Dears, for Dilution is the Solution!
Mine wit is curious to see, how we thee faire, at open in the morrow!
|
|
|
Post by ilovekauai on Mar 29, 2019 18:02:19 GMT -5
Indeed BT 88.
And while I'm at it, last time I checked, MNKD Company HQ is located in Thousand Oaks, CA, not NYC. This is where the ASM should be held w/o question! So now the ASM that I had planned to attend again this year in Thousand Oaks, is in some fancy hotel in NYC, on the other side of the country from where it should be, (or at least in Danbury CT, where the plant is), making it very expensive for us to make it over there, and plus management gets to avoid many of us investors who aren't happy, while happily depositing themselves, dropping coin, to put themselves up in NYC? Is this a a joke?
What I liked about last year at the ASM was the chance to meet and mingle with mid-level staff, as well as upper management, to gauge their effectiveness and happiness in being part of MNKD. Well all of that is out the window now for this year. We won't see the underlings at the ASM. Trust with me at least as a long holding investor is fragile, at best right now.
I just hope those few investors attending the ASM in the middle of NYC (!) this year can ask some hard questions!
|
|